JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Appella, E.
Right arrow Articles by Blasi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Appella, E.
Right arrow Articles by Blasi, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 262, Issue 10, 4437-4440, Apr, 1987

The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases

E Appella, EA Robinson, SJ Ullrich, MP Stoppelli, A Corti, G Cassani and F Blasi

Previous studies have shown that the region of human urokinase-type plasminogen activator (uPA) responsible for receptor binding resides in the amino-terminal fragment (ATF, residues 1-135) (Stoppelli, M.P., Corti, A., Soffientini, A., Cassani, G., Blasi, F., and Assoian, R.K. (1985) Proc. Natl. Acad. Sci. U.S. A. 82, 4939-4943). The area within ATF responsible for specific receptor binding has now been identified by the ability of different synthetic peptides corresponding to different regions of the amino terminus of uPA to inhibit receptor binding of 125I-labeled ATF. A peptide corresponding to human [Ala19]uPA-(12-32) resulted in 50% inhibition of ATF binding at 100 nM. Peptides uPA-(18-32) and [Ala13]uPA-(9-20) inhibit at 100 and 2000 microM, respectively. The human peptide uPA-(1-14) and the mouse peptide [Ala20]uPA-(13-33) have no effect on ATF receptor binding. This region of uPA is referred to as the growth factor module since it shares partial amino acid sequence homology (residues 14-33) to epidermal growth factor (EGF). Furthermore, this region of EGF is responsible for binding of EGF to its receptor (Komoriya, A. Hortsch, M., Meyers, C., Smith, M., Kanety, H., and Schlessinger, J. (1984) Proc. Natl. Acad. Sci. U.S.A. 81, 1351-1355). However, EGF does not inhibit ATF receptor binding. Comparison of the sequences responsible for receptor binding of uPA and EGF indicate that the region of highest homology is between residues 13-19 and 14-20 of human uPA and EGF, respectively. In addition, there is a conservation of the spacings of four cysteines in this module whereas there is no homology between residues 20-30 and 21-33 of uPA and EGF. Thus, residues 20-30 of uPA apparently confer receptor binding specificity, and residues 13-19 provide the proper conformation to the adjacent binding region.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
V. Stepanova, T. Lebedeva, A. Kuo, S. Yarovoi, S. Tkachuk, S. Zaitsev, K. Bdeir, I. Dumler, M. S. Marks, Y. Parfyonova, et al.
Nuclear translocation of urokinase-type plasminogen activator
Blood, July 1, 2008; 112(1): 100 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hillig, L. H. Engelholm, S. Ingvarsen, D. H. Madsen, H. Gardsvoll, J. K. Larsen, M. Ploug, K. Dano, L. Kjoller, and N. Behrendt
A Composite Role of Vitronectin and Urokinase in the Modulation of Cell Morphology upon Expression of the Urokinase Receptor
J. Biol. Chem., May 30, 2008; 283(22): 15217 - 15223.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhang, Z.-H. Zhou, T. H. Bugge, and L. M. Wahl
Urokinase-Type Plasminogen Activator Stimulation of Monocyte Matrix Metalloproteinase-1 Production Is Mediated by Plasmin-Dependent Signaling through Annexin A2 and Inhibited by Inactive Plasmin
J. Immunol., September 1, 2007; 179(5): 3297 - 3304.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Franco, I. Vocca, M. V. Carriero, D. Alfano, L. Cito, I. Longanesi-Cattani, P. Grieco, L. Ossowski, and M. P. Stoppelli
Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and {alpha}v{beta}5 integrin
J. Cell Sci., August 15, 2006; 119(16): 3424 - 3434.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Alfano, I. Iaccarino, and M. P. Stoppelli
Urokinase Signaling through Its Receptor Protects against Anoikis by Increasing BCL-xL Expression Levels
J. Biol. Chem., June 30, 2006; 281(26): 17758 - 17767.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. Mazzieri, S. D'Alessio, R. K. Kenmoe, L. Ossowski, and F. Blasi
An Uncleavable uPAR Mutant Allows Dissection of Signaling Pathways in uPA-dependent Cell Migration
Mol. Biol. Cell, January 1, 2006; 17(1): 367 - 378.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
S. Zhang, C. Chen, L. Li, L. Meng, J. Singh, N. Jiang, X.-W. Deng, Z.-H. He, and P. G. Lemaux
Evolutionary Expansion, Gene Structure, and Expression of the Rice Wall-Associated Kinase Gene Family
Plant Physiology, November 1, 2005; 139(3): 1107 - 1124.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Degryse, M. Resnati, R.-P. Czekay, D. J. Loskutoff, and F. Blasi
Domain 2 of the Urokinase Receptor Contains an Integrin-interacting Epitope with Intrinsic Signaling Activity: GENERATION OF A NEW INTEGRIN INHIBITOR
J. Biol. Chem., July 1, 2005; 280(26): 24792 - 24803.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Pluskota, D. A. Soloviev, K. Bdeir, D. B. Cines, and E. F. Plow
Integrin {alpha}M{beta}2 Orchestrates and Accelerates Plasminogen Activation and Fibrinolysis by Neutrophils
J. Biol. Chem., April 23, 2004; 279(17): 18063 - 18072.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
J. A. Verica, L. Chae, H. Tong, P. Ingmire, and Z.-H. He
Tissue-Specific and Developmentally Regulated Expression of a Cluster of Tandemly Arrayed Cell Wall-Associated Kinase-Like Kinase Genes in Arabidopsis
Plant Physiology, December 1, 2003; 133(4): 1732 - 1746.
[Abstract] [Full Text]


Home page
BloodHome page
K. Bdeir, A. Kuo, B. S. Sachais, A. H. Rux, Y. Bdeir, A. Mazar, A. A.-R. Higazi, and D. B. Cines
The kringle stabilizes urokinase binding to the urokinase receptor
Blood, November 15, 2003; 102(10): 3600 - 3608.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. C. Shin and W. R. Folk
Formation of Polyomavirus-Like Particles with Different VP1 Molecules That Bind the Urokinase Plasminogen Activator Receptor
J. Virol., November 1, 2003; 77(21): 11491 - 11498.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. G. McGuire, T. R. Jones, N. Talarico, E. Warren, and A. Das
The Urokinase/Urokinase Receptor System in Retinal Neovascularization: Inhibition by A6 Suggests a New Therapeutic Target
Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2736 - 2742.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. S. Kim, Y.-K. Hong, Y. A. Joe, Y. Lee, J.-Y. Shin, H.-E. Park, I.-H. Lee, S.-Y. Lee, D.-K. Kang, S.-I. Chang, et al.
Anti-angiogenic Activity of the Recombinant Kringle Domain of Urokinase and Its Specific Entry into Endothelial Cells
J. Biol. Chem., March 21, 2003; 278(13): 11449 - 11456.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Pluskota, D. A. Soloviev, and E. F. Plow
Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration
Blood, February 15, 2003; 101(4): 1582 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Guo, A. P. Mazar, J.-J. Lebrun, and S. A. Rabbani
An Antiangiogenic Urokinase-derived Peptide Combined with Tamoxifen Decreases Tumor Growth and Metastasis in a Syngeneic Model of Breast Cancer
Cancer Res., August 15, 2002; 62(16): 4678 - 4684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Sidenius, A. Andolfo, R. Fesce, and F. Blasi
Urokinase Regulates Vitronectin Binding by Controlling Urokinase Receptor Oligomerization
J. Biol. Chem., July 26, 2002; 277(31): 27982 - 27990.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. A. Vallera, C. Li, N. Jin, A. Panoskaltsis-Mortari, and W. A. Hall
Targeting Urokinase-Type Plasminogen Activator Receptor on Human Glioblastoma Tumors With Diphtheria Toxin Fusion Protein DTAT
J Natl Cancer Inst, April 17, 2002; 94(8): 597 - 606.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wang, L. Shao, S. Shi, R. J. Harris, M. W. Spellman, P. Stanley, and R. S. Haltiwanger
Modification of Epidermal Growth Factor-like Repeats with O-Fucose. MOLECULAR CLONING AND EXPRESSION OF A NOVEL GDP-FUCOSE PROTEIN O-FUCOSYLTRANSFERASE
J. Biol. Chem., October 19, 2001; 276(43): 40338 - 40345.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
D. Lally, P. Ingmire, H.-Y. Tong, and Z.-H. He
Antisense Expression of a Cell Wall-Associated Protein Kinase, WAK4, Inhibits Cell Elongation and Alters Morphology
PLANT CELL, June 1, 2001; 13(6): 1317 - 1332.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
L. Kjoller and A. Hall
Rac Mediates Cytoskeletal Rearrangements and Increased Cell Motility Induced by Urokinase-type Plasminogen Activator Receptor Binding to Vitronectin
J. Cell Biol., March 12, 2001; 152(6): 1145 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. A. Bezerra, A. R. Currier, H. Melin-Aldana, G. Sabla, T. H. Bugge, K. W. Kombrinck, and J. L. Degen
Plasminogen Activators Direct Reorganization of the Liver Lobule after Acute Injury
Am. J. Pathol., March 1, 2001; 158(3): 921 - 929.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Klippel, E. Strunck, S. Roder, M. Lubbert, W. Lange, M. Azemar, G. Meinhardt, H.-E. Schaefer, and H. L. Pahl
Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera
Blood, April 15, 2000; 95(8): 2569 - 2576.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Moloney, L. H. Shair, F. M. Lu, J. Xia, R. Locke, K. L. Matta, and R. S. Haltiwanger
Mammalian Notch1 Is Modified with Two Unusual Forms of O-Linked Glycosylation Found on Epidermal Growth Factor-like Modules
J. Biol. Chem., March 24, 2000; 275(13): 9604 - 9611.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Webb, D. H. D. Nguyen, M. Sankovic, and S. L. Gonias
The Very Low Density Lipoprotein Receptor Regulates Urokinase Receptor Catabolism and Breast Cancer Cell Motility in Vitro
J. Biol. Chem., March 12, 1999; 274(11): 7412 - 7420.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Sugiura, L. Ma, B. Sun, H. Shimada, W. E. Laug, R. C. Seeger, and Y. A. DeClerck
The Plasminogen-Plasminogen Activator (PA) System in Neuroblastoma: Role of PA Inhibitor-1 in Metastasis
Cancer Res., March 1, 1999; 59(6): 1327 - 1336.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ploug, H. Rahbek-Nielsen, P. F. Nielsen, P. Roepstorff, and K. Dano
Glycosylation Profile of a Recombinant Urokinase-type Plasminogen Activator Receptor Expressed in Chinese Hamster Ovary Cells
J. Biol. Chem., May 29, 1998; 273(22): 13933 - 13943.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. H. A. Quax, J. M. Grimbergen, M. Lansink, A. H. F. Bakker, M.-C. Blatter, D. Belin, V. W. M. van Hinsbergh, and J. H. Verheijen
Binding of Human Urokinase-Type Plasminogen Activator to Its Receptor : Residues Involved in Species Specificity and Binding
Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 693 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. H. D. Nguyen, I. M. Hussaini, and S. L. Gonias
Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility
J. Biol. Chem., April 3, 1998; 273(14): 8502 - 8507.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
V. Cirulli, L. Crisa, G.M. Beattie, M.I. Mally, A.D. Lopez, A. Fannon, A. Ptasznik, L. Inverardi, C. Ricordi, T. Deerinck, et al.
KSA Antigen Ep-CAM Mediates Cell-Cell Adhesion of Pancreatic Epithelial Cells: Morphoregulatory Roles in Pancreatic Islet Development
J. Cell Biol., March 23, 1998; 140(6): 1519 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. Plesner, N. Behrendt, and M. Ploug
Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase-Type Plasminogen Activator Receptor, uPAR
Stem Cells, November 1, 1997; 15(6): 398 - 408.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. M. Regan, J. S. Mollica, A. R. Rezaie, and C. T. Esmon
The Interaction between the Endothelial Cell Protein C Receptor and Protein C Is Dictated by the gamma -Carboxyglutamic Acid Domain of Protein C
J. Biol. Chem., October 17, 1997; 272(42): 26279 - 26284.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Tran, W. J. VanDusen, and W. S. Argraves
The Self-association and Fibronectin-binding Sites of Fibulin-1 Map to Calcium-binding Epidermal Growth Factor-like Domains
J. Biol. Chem., September 5, 1997; 272(36): 22600 - 22606.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
R. Ciccocioppo, M. G. Capri, and S. Alberti
Detection of the Receptor for the Human Urokinase-type Plasminogen Activator Using Fluoresceinated uPA
J. Histochem. Cytochem., September 1, 1997; 45(9): 1307 - 1314.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Ginestra, S. Monea, G. Seghezzi, V. Dolo, H. Nagase, P. Mignatti, and M. L. Vittorelli
Urokinase Plasminogen Activator and Gelatinases Are Associated with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma Cells
J. Biol. Chem., July 4, 1997; 272(27): 17216 - 17222.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Li, E. G. Karakji, R. Xing, J. N. Fryer, J. A. Carnegie, S. A. Rabbani, and B. K. Tsang
Expression of Urokinase-Type Plasminogen Activator and Its Receptor during Ovarian Follicular Development
Endocrinology, July 1, 1997; 138(7): 2790 - 2799.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
P. Franco, C. Iaccarino, F. Chiaradonna, A. Brandazza, C. Iavarone, M. R. Mastronicola, M. L. Nolli, and M. P. Stoppelli
Phosphorylation of Human Pro-Urokinase on Ser138/303 Impairs Its Receptor-dependent Ability to Promote Myelomonocytic Adherence and Motility
J. Cell Biol., May 5, 1997; 137(3): 779 - 791.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Ambrosini, J. Plescia, K. C. Chu, K. A. High, and D. C. Altieri
Activation-dependent Exposure of the Inter-EGF Sequence Leu83-Leu88 in Factor Xa Mediates Ligand Binding to Effector Cell Protease Receptor-1
J. Biol. Chem., March 28, 1997; 272(13): 8340 - 8345.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. A.-R. Higazi, A. Mazar, J. Wang, N. Quan, R. Griffin, R. Reilly, J. Henkin, and D. B. Cines
Soluble Human Urokinase Receptor Is Composed of Two Active Units
J. Biol. Chem., February 21, 1997; 272(8): 5348 - 5353.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S Bonavaud, C Charriere-Bertrand, C Rey, M. Leibovitch, N Pedersen, E Frisdal, E Planus, F Blasi, R Gherardi, and G Barlovatz-Meimon
Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion
J. Cell Sci., January 5, 1997; 110(9): 1083 - 1089.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Rogers, F. G.P. Welt, M. J. Karnovsky, and E. R. Edelman
Monocyte Recruitment and Neointimal Hyperplasia in Rabbits: Coupled Inhibitory Effects of Heparin
Arterioscler. Thromb. Vasc. Biol., October 1, 1996; 16(10): 1312 - 1318.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. Behrendt, E. Ronne, and K. Dano
Domain Interplay in the Urokinase Receptor. REQUIREMENT FOR THE THIRD DOMAIN IN HIGH AFFINITY LIGAND BINDING AND DEMONSTRATION OF LIGAND CONTACT SITES IN DISTINCT RECEPTOR DOMAINS
J. Biol. Chem., September 13, 1996; 271(37): 22885 - 22894.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. H. Bugge, T. T. Suh, M. J. Flick, C. C. Daugherty, J. R, H. Solberg, V. Ellis, K. Danø, and J. L. Degen
The Receptor for Urokinase-type Plasminogen Activator Is Not Essential for Mouse Development or Fertility
J. Biol. Chem., July 14, 1995; 270(28): 16886 - 16894.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-I W. Q. Y. and Charles S. Craik and C. I. Wang
Isolation of a High Affinity Inhibitor of Urokinase-type Plasminogen Activator by Phage Display of Ecotin
J. Biol. Chem., May 19, 1995; 270(20): 12250 - 12256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Mandriota, G. Seghezzi, J.-D. Vassalli, N. Ferrara, S. Wasi, R. Mazzieri, P. Mignatti, and M. S. Pepper
Vascular Endothelial Growth Factor Increases Urokinase Receptor Expression in Vascular Endothelial Cells
J. Biol. Chem., April 28, 1995; 270(17): 9709 - 9716.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Novokhatny, L. Medved, H. R. Lijnen, and K. Ingham
Tissue-type Plasminogen Activator (tPA) Interacts with Urokinase-type Plasminogen Activator (uPA) via tPA's Lysine Binding Site
J. Biol. Chem., April 14, 1995; 270(15): 8680 - 8685.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Naldini, E. Vigna, A. Bardelli, A. Follenzi, F. Galimi, and P. M. Comoglio
Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction
J. Biol. Chem., January 13, 1995; 270(2): 603 - 611.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
P. McGuire and S. Alexander
Inhibition of urokinase synthesis and cell surface binding alters the motile behavior of embryonic endocardial-derived mesenchymal cells in vitro
Development, January 7, 1993; 118(3): 931 - 939.
[Abstract] [PDF]


Home page
DevelopmentHome page
F. Del Amo, D. Smith, P. Swiatek, M Gendron-Maguire, R. Greenspan, A. McMahon, and T Gridley
Expression pattern of Motch, a mouse homolog of Drosophila Notch, suggests an important role in early postimplantation mouse development
Development, January 7, 1992; 115(3): 737 - 744.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
O. D. Liang, T. Chavakis, S. M. Kanse, and K. T. Preissner
Ligand Binding Regions in the Receptor for Urokinase-type Plasminogen Activator. STRUCTURAL REQUIREMENTS FOR A MULTIDOMAIN BINDING REGION AND RECEPTOR-RECEPTOR INTERACTION
J. Biol. Chem., July 27, 2001; 276(31): 28946 - 28953.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Mukhina, V. Stepanova, D. Traktouev, A. Poliakov, R. Beabealashvilly, Y. Gursky, M. Minashkin, A. Shevelev, and V. Tkachuk
The Chemotactic Action of Urokinase on Smooth Muscle Cells Is Dependent on Its Kringle Domain. CHARACTERIZATION OF INTERACTIONS AND CONTRIBUTION TO CHEMOTAXIS
J. Biol. Chem., May 26, 2000; 275(22): 16450 - 16458.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1987 by the American Society for Biochemistry and Molecular Biology.